Under close review, analysts found that significantly more funding was given to research into the negative effects of cannabis and cannabis misuse than on its medical and therapeutic uses.
A new study of 21 American CBD products, currently in preprint, has found evidence that many products are mislabeled, contaminated, and deliberately adulterated.
While the cannabis-consuming patients were on average 15 years younger than the other patients - a factor that could help them recover from injuries at a faster rate - the study’s authors still say THC could have afforded some protective effect.
Published in the British Journal of Pharmacology, the new study found that THC could relieve inflamed pathways in the lungs of lab mice, as well as benefit the bacteria living the rodents’ lungs and guts.
Stored cannabis vape cartridges and lead leaching may pose a risk to consumer health, an early study shared with Analytical Cannabis has found.
The new study found that states without a legal recreational marijuana market were more likely to have more EVALI cases per capita.
The FDA is looking to hire a contractor to study thousands of CBD product samples to help the administration develop regulations for products containing the compound.